Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

W81XWH-21-TBIPHRP-CRDA: DoD Traumatic Brain Injury and Psychological Health, Clinical Research Development Award

Closed Closed October 7, 2021 Opportunity W81XWH-21-TBIPHRP-CRDA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2021.

• Total funding$3.0 million
• Expected awards10
• Cost sharingNot required
• Funding typeCooperative Agreement, Grant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The FY21 TBIPHRP CRDA is intended to support planning and development activities necessary to initiate a future clinical study with the potential to have a significant impact on TBI and/or psychological health. The future study to be developed at the conclusion of the CRDA may be clinical research or a clinical trial. A clinical trial is defined as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes. As stated in Section II.H.2.c, Withdrawal, FY21 TBIPHRP CRDA applications that propose clinical research or a clinical trial in the CRDA period of performance may be administratively withdrawn. Clinical research is defined as: (1) patient-oriented research. Research conducted with prospectively enrolled human subjects (or on material of human origin such as tissues, specimens, and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. Excluded from this definition are in vitro studies that utilize human tissues that cannot be linked to a living individual. Patient-oriented research includes: (a) mechanisms of human disease, (b) therapeutic interventions, (c) clinical trials, and (d) development of new technologies; (2) epidemiologic and behavioral studies; and (3) outcomes research and health services research. Note: Studies that meet the requirements for Institutional Review Board (IRB) Exemption 4 are not considered CDMRP-defined clinical research. IRB Exemption 4 refers to research involving the collection or study of existing de-identified specimens or data, if these sources are publicly available. FY21 TBIPHRP CRDA recipients are expected to be ready to apply for advanced funding in the program year following completion of their CRDA and are encouraged to apply for future TBIPHRP funding through an appropriate FY23 or FY24 TBIPHRP program announcement or targeted broad agency announcement, if offered. Release of FY23 or FY24 TBIPHRP funding opportunity announcements and any subsequent awards will be contingent upon the appropriation and availability of federal funds for the program and competitive selection. Award of an FY21 TBIPHRP CRDA is in no way an assurance of funding for future TBIPHRP awards.

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.